Clinical trial
Additive Effect of Ezetimibe Upon Simvastatin Treatment on Systemic Inflammatory Activity and Endothelial Function During Myocardial Infarction
NCT00905905 is registered in ClinicalTrials.gov with Brasilia Heart Study Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Additive Effect of Ezetimibe Upon Simvastatin Treatment on Systemic Inflammatory Activity and Endothelial Function During Myocardial Infarction
- Lead sponsor
- Brasilia Heart Study Group
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- January 31, 2010
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.